Artificial Intelligence and Machine Learning (AI/ML) have applications across all areas of drug discovery and development. At Open Targets, our main focus is target identification and prioritisation, and a 2017 analysis by Enrico Ferrero shows that the data linking genes and diseases in the Open Targets Platform is already sufficient to effectively predict novel targets for which therapies are actively being pursued or are already on the market.
This is a companion discussion topic for the original entry at https://blog.opentargets.org/machine-learning-for-drug-target-identification-and-prioritisation-at-open-targets/